Lanthionine synthetase C-like 2-based therapeutics

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF

SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF

PRC1 inhibitors and methods of treatment therewith

Benzimidazole derivative having JNK inhibitory activity and use thereof

Benzimidazole compounds as c-Kit inhibitors

Aminopyrimidinyl compounds

3-CARBOXYLIC ACID PYRROLES AS NRF2 REGULATORS

Compositions and methods for inhibiting kinases

Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound

AURKB SMALL-MOLECULE INHIBITORS AND USES THEREOF

Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same

Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof

ORGANIC ELECTROLUMINESCENCE DEVICE

Inhibitors of cyclin-dependent kinases

Carbohydrate-binding small molecules with antiviral activity

Difluoromethyl-phenyl triazoles

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Hydantoin containing deoxyuridine triphosphatase inhibitors

Cyanopyrrolidine derivatives with activity as inhibitors of USP30

Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Organic electroluminescent compound and organic electroluminescent device comprising the same

Organic electroluminescent device

1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases

INDOLIN-2-ONE OR PYRROLO-PYRIDIN-2-ONE DERIVATIVES

Bipyrazole derivatives as JAK inhibitors

Substituted quinazoline and quinazolinone compounds and methods of use thereof

NLRX1 ligands

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

Light-emitting element, light-emitting device, electronic device, lighting device, and organic compound

Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

Compounds and compositions for inhibiting the activity of SHP2

AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS

Condensed cyclic compound and organic light-emitting device including the same

Benzimidazole derivatives

Aminopyrazine derivatives as PI3K-γ inhibitors

Inhibitors of EGFR and methods of use thereof

Phthalazinone derivatives

METHOD AND DEVICE FOR DETERMINING A LEVEL OF COLONISATION OF ACNE BACTERIA ON SKIN

Organic molecules for use in organic optoelectronic devices

2-arylsulfonamido-N-arylacetamide derivatized STAT3 inhibitors

PYRROLE mTORC INHIBITORS AND USES THEREOF

Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS

Materials for electronic devices

Inhibiting agents for Bruton's tyrosine kinase

Bromodomain Inhibitors

NOVEL COMPOUNDS

Carboxamide compounds and uses thereof

Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors

Substituted glycine derived FXIA inhibitors

(HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY

Metalloenzyme inhibitor compounds

Pyrazole derivatives as MALT1 inhibitors

3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

Prodigiosin analogs and methods of use

Compounds for the treatment of HIV

HETEROCYCLIC COMPOUNDS AND USES THEREOF

JAK1 selective inhibitors

Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

Imidazolyl kinase inhibitors and uses thereof

Benzoimidazoles as prolyl hydroxylase inhibitors

Inhibitors of hepatitis C virus

Heteroaryl SYK inhibitors

1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use thereof in the treatment of cancer

Compounds useful for treating gastrointestinal tract disorders

Heteroaromatic derivatives as NIK inhibitors

PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Amide compounds and method for making and using

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME

2,4-pyrimidinediamine compounds and their uses

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

Ferroportin inhibitors

Heparanase inhibitors and use thereof

ARYL-SUBSTITUTED IMIDAZOLES

SGC STIMULATORS

PROCESS FOR PREPARATION OF DACLATASVIR AND SALTS

Pyrimidinone derivatives as Cdc7 inhibitors

AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER

Condensed cyclic compound and organic light-emitting device including i he same

Benzopiperazine compositions as BET bromodomain inhibitors

Pyridazinones as PARP7 inhibitors

Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof

SUBSTITUTED AZOLYLPYRROLONES AND AZOLYLHYDANTOINS AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES

2-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof

4-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors

Aliphatic prolinamide derivatives

Heterocyclic compound and harmful arthropod controlling agent containing same

CXCR4 inhibitors and uses thereof

5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF

SMYD INHIBITORS

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

1-cyano-pyrrolidine compounds as USP30 inhibitors

GLUT4 Selective Inhibitors for Cancer Therapy

Organic electroluminescence device and nitrogen-containing compound for organic electroluminescence device

Condensed cyclic compound and organic light-emitting device including the same

Pyrazol-3-ones that activate pro-apoptotic BAX

Hydroxyalkyl-substituted triazole derivatives and uses thereof

5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis

Benzimidazole and indole compounds and uses thereof

Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme

Arylamide compounds and compositions and uses thereof

Antifungal agents

Heterocyclic compound and organic light emitting element using same

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

Rho kinase inhibitors

Quinoxaline compounds as type III receptor tyrosine kinase inhibitors

Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same

NOVEL PIPERIDINE DERIVATIVES

Dopamine Dreceptor antagonist compounds

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors

Composition of matter for use in organic light-emitting diodes

Binding Function 3 (BF3) site compounds as therapeutics and methods for their use

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

YAP1 inhibitors and methods

Heterocyclic compounds for use in electronic devices

Method for sealing a void in a well using a smart gel sealant

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Alkylating agent for alkylating target with driver oncogene mutation

Substituted quinoxaline DNA-PK inhibitors

Cycloalkyl substituted triazole compounds as agonists of the APJ receptor

Alkyl substituted triazole compounds as agonists of the APJ Receptor

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Organic molecules for optoelectronic devices

Triazole phenyl compounds as agonists of the APJ receptor

PYRAZOLE DERIVATIES AS SGC STIMULATORS

Substituted quinazoline compounds and methods of use thereof

1-cyano-pyrrolidine compounds as USP30 inhibitors

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF

Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

Pharmaceutical compounds

Aminopyrazine diol compounds as PI3K-γ inhibitors

IRE1 small molecule inhibitors

Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid

Process for the synthesis of amide bonds with the aid of novel catalysts

Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain

GLS1 inhibitors for treating disease

PD-1/PD-L1 inhibitors

1-cyano-pyrrolidine compounds as USP30 inhibitors

5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

Benzimidazole-proline derivatives

Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases

Pyridazine derivatives as RORc modulators

Spirocyclic containing compounds and pharmaceutical uses thereof

Pharmaceutical compounds

Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase

Heterocyclic amides as kinase inhibitors

Indazole compounds and uses thereof

Indazole compounds and uses thereof

SUBSTITUTED QUINOXALINE DERIVATIVES AS INHIBITORS OF PFKFB

CRYSTALLINE FORMS OF DACLATASVIR DIHYDROCHLORIDE

CTB-PI polyamide conjugate for activating expression of specific gene

SMAC mimetic

DNA-PK inhibitors

2,4-pyrimidinediamine compounds and their uses

Antibacterial agents based on ciprofloxacin derivatives

Tetrahydroquinazoline derivatives useful as anticancer agents

Pyridone compound as c-met inhibitor

Organic molecules for use in organic optoelectronic devices

Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same

3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

Catalyst for curable compositions containing hexahydrotriazine structural units

Heterocyclic compound and organic light-emitting device including the same

Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents

Composition of matter for use in organic light-emitting diodes

Indole derivatives as estrogen receptor degraders

Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof

Compounds

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

Dicyanopyrazine compound, luminescent material, luminescence device using the same, and method for producing 2,5-dicyano-3,6-dihalogenopyrazine

5,12-dihydrotetracene derivative and organic electroluminescence device using the same

Dihydropyrimidine compound and preparation method and use thereof

Heterocyclic compounds and their use in preventing or treating bacterial infections

Substituted aminopyrimidine compounds and methods of use

PYRIDINYL AND FUSED PYRIDINYL TRIAZOLONE DERIVATIVES

HETEROARYL COMPOUNDS FOR KINASE INHIBITION

Pyrazole derivatives as plasma kallikrein inhibitors

Potassium channel modulators

Substituted bicyclic compounds as bromodomain inhibitors

THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, POLYMER, MIXTURE, FORMULATION, AND ORGANIC ELECTRONIC DEVICE

LIGHT EMITTING ELECTROCHEMICAL CELLS AND COMPOUNDS

Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

Inhibitors of LDLR-PCSK9 protein-protein interaction and methods of their use

HIV protease inhibitors

Inhibitors of fibroblast growth factor receptor and use thereof

Crystal Forms

Carbocyclic prolinamide derivatives

Biarylmethyl heterocycles

Piperazine carbamates and methods of making and using same

Heterocyclic amides as kinase inhibitors

Composition of matter for use in organic light-emitting diodes

Heterocyclic compound and organic light-emitting device including the same

Organic electroluminescence device and compound including nitrogen for organic electroluminescence device

ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS EQUIPPED WITH SAME

PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS

Organic molecules for use in organic optoelectronic devices

Pyrimidines as EGFR inhibitors and methods of treating disorders

Compounds with spirobifluorene-structures

Inhibitors of lysine specific demethylase-1

Inhibitor of lysine specific demethylase-1

toxin inhibitors

Organic light-emitting element, and light-emitting material and compound for use therein

Organic electroluminescent materials and devices

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Substituted Pyrrolidine Amides II

Diaryl-azole compound and formulation for controlling harmful organism

HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND

Inhibitors of influenza virus replication, application methods and uses thereof

Substituted pyrrolidine amides I

Inhibitors of RET

Triazoles for the treatment of demyelinating dieases

Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof

TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS

Organic molecules for use in optoelectronic devices

Pharmacokinetically improved compounds

Organic molecules for use in optoelectronic devices

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

Compound for organic electronic element, organic electronic element using the same, and electronic device thereof

NITROGEN HETEROCYCLE-FUSED BENZENE-BENZIMIDAZOLE ORGANIC COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS

COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES

Bis-pyridazine compounds and their use in treating cancer

Dicyanopyrazine compound, luminescent material, luminescence device using the same, and method for producing 2,5-dicyano-3,6-dihalogenopyrazine

Small molecule activators of Parkin enzyme function

Materials for organic electroluminescent devices

Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease

Small molecule inhibitors of EGFR and PI3K

Pyrimidine derivatives and their use in treating or preventing a respiratory syncytial virus infection

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

Heterocycle-substituted bicyclic azole pesticides

Pyrimidine derivative, method for preparing same and use thereof in medicine

Modulators of calcium release-activated calcium channel

Organic light-emitting device

Compound and organic electroluminescent device comprising same

Transcriptome-wide design of selective, bioactive small molecules targeting RNA

Polydentate binuclear ring metal complexes and devices containing same

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2

Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereof

Triazolones and tetrazolones as inhibitors of ROCK

Substituted guanidine derivatives

5-aminopyrazole carboxamide derivative as BTK inhibitor and preparation method and pharmaceutical composition thereof

Inhibitors of plasma kallikrein

Benzazepine derivative, preparation method, pharmaceutical composition and use thereof

Bis-benzimidazole compounds and methods of using the same

Compound, organic electroluminescent element material using same, organic electroluminescent element using this material, and electronic device

Amino compounds for treatment of complement mediated disorders

Inhibitors of the menin-MLL interaction

Compositions useful for treating disorders related to kit

Metallo-beta-lactamase inhibitors

Bicyclic proline compounds

Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof

Arylquinazolines

Organic electroluminescent materials and devices

Quinazoline and indole compounds to treat medical disorders

Benzimidazole-linked indole compound acting as novel divalent IAP antagonist

HETEROCYCLIC INHIBITORS OF KDM5 FOR THE TREATMENT OF DISEASE

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Heterocyclic compound and pharmaceutical composition comprising same

Triazine based radiopharmaceuticals and radioimaging agents

MODULATORS OF CELLULAR ADHESION

Compound including nitrogen and organic electroluminescence device including the same

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Pyrimidine compound and pharmaceutical use thereof

Heterocyclic compound and organic light-emitting device comprising same

Substituted quinazoline compounds and methods of use

Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents

Lanthionine synthetase C-like 2-based therapeutics

CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

Compositions and methods for inhibiting kinases

CELL PENETRATING CYANINE-COUPLED ANTIBODIES

AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF

PKM2 modulators and methods for their use

Prodigiosin analogs

Compounds and their use for reducing uric acid levels

Organic molecules for use in optoelectronic devices

Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones

Heterocyclic inhibitors of MCT4

Compound having mutant IDH inhibitory activity, preparation method and use thereof

Azetidine-substituted fluorescent compounds

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS

SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS

Heterocyclic compound

COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES

NIR to SWIR fluorescent compounds for imaging and detection

Organic molecules for use in optoelectronic devices

Energetic compounds and compositions

Inhibitors of KRAS G12C mutant proteins